This half-day symposium brought together a unique community of physicians, healthcare professionals, researchers, patients and patient advocates to learn about the latest scientific and clinical developments in the diagnosis, treatment and care of patients with lung cancer.

National Cancer Institute Director and Nobel Laurate, Dr. Harold Varmus, spoke about the dramatically expanding opportunities in lung cancer research and treatment, and how the NCI is addressing the challenges bringing these opportunities to patients.

Listen to a podcast of Dr. Varmas' keynote address:
Part 1
Part 2
Part 3
(To download, right click on each of the links above and click "Save File" or "Save Link As")

Interactive panel discussions, led by internationally renowned faculty, included:

National Lung Screening Trial: Ramifications and Challenges Moving Forward
• Developing Guidelines for Lung Cancer Screening
• Innovations in Minimally Invasive Surgical Procedures
• Advances in Biomarker Development for Risk Assessment and Early Detection

State of the Art in Lung Cancer Treatment
• Adaptive clinical trial designs
• Targeting the MET Signaling Pathway
• Second-Generation EGFR Inhibitors
• Palliative Care

This meeting also highlighted the research of National Lung Cancer Partnership grant recipients.

Download the agenda

More Details:
Continuing Medical Education information and learning objectives

We are grateful to the following companies for sponsoring the 2011 Annual Meeeting:
Pfizer
Amgen
Merck
Morphotek
Daiichi Sankyo

Read more about our past Annual Meetings:
2010
2009
2008
Prior to 2008